Segmentectomy in Lung Cancer as a New Standard of Treatment: Can Less Be More?

Isea de la Viña, JesusRamirez-Rodriguez, GemaAlcazar-Navarrete, Bernardino2023-05-032023-05-032022-06-20Isea de la Viña J, Ramírez-Rodríguez G, Alcázar-Navarrete B. Segmentectomy in Lung Cancer as a New Standard of Treatment: Can Less Be More? Arch Bronconeumol. 2022 Oct;58(10):687-688.http://hdl.handle.net/10668/22016Non-small cell lung cancer (NSCLC) remains the leading cause of cancer death worldwide,1 especially in patients with chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD). In recent decades, however, efforts to prevent, diagnose, and treat NSCLC have led to a decline in age-adjusted mortality rates (especially in men)2 and the detection of smaller tumors at the time of diagnosis.enTreatment OutcomeNeoplasm StagingCarcinoma, Non-Small-Cell LungHumansLung NeoplasmsPneumonectomyRetrospective StudiesSegmentectomy in Lung Cancer as a New Standard of Treatment: Can Less Be More?research article35879121Restricted AccessEstudios retrospectivosHumanosNeumonectomíaNeoplasias pulmonares10.1016/j.arbres.2022.05.0151579-2129